Single-Dose Gene Therapy Demonstrates Sustained Cholesterol Reduction

Early clinical trials indicate that a single-dose gene-editing therapy can significantly lower LDL cholesterol levels for at least a year. Researchers view the experimental treatment as a potential long-term solution for managing cardiovascular disease risk.